161 related articles for article (PubMed ID: 10649731)
41. Responsive estrogen-induced aplastic anemia in a dog.
Van Kruiningen HJ; Friedland TB
J Am Vet Med Assoc; 1987 Jul; 191(1):91-2. PubMed ID: 3610789
[TBL] [Abstract][Full Text] [Related]
42. Serum erythropoietin concentrations in patients with anemia--preliminary hemoglobin-related reference ranges.
Vogeser M; Schiel X
Clin Lab; 2002; 48(11-12):595-8. PubMed ID: 12465743
[TBL] [Abstract][Full Text] [Related]
43. [Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
Queipo Zaragozá JA; Chicote Pérez F; Beltrán Meseguer JF; Borrell Palanca A; Giner Marco V; Esteve Claramunt J; Pastor Sempere F
Arch Esp Urol; 2004; 57(1):35-40. PubMed ID: 15112869
[TBL] [Abstract][Full Text] [Related]
44. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
45. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Kimata N; Akiba T; Pisoni RL; Albert JM; Satayathum S; Cruz JM; Akizawa T; Andreucci VE; Young EW; Port FK
Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270
[TBL] [Abstract][Full Text] [Related]
46. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
[TBL] [Abstract][Full Text] [Related]
47. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
48. [Spanish survey on anaemia management].
Pérez García R
Nefrologia; 2003; 23(4):300-11. PubMed ID: 14558329
[TBL] [Abstract][Full Text] [Related]
49. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
50. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
51. Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies.
Schroeder ET; Terk M; Sattler FR
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E16-24. PubMed ID: 12637255
[TBL] [Abstract][Full Text] [Related]
52. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
53. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha B; Rajadhyaksha GC; Ray SK
J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
[TBL] [Abstract][Full Text] [Related]
54. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
Williams JS; Stein JH; Ferris TF
Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
[No Abstract] [Full Text] [Related]
55. [Treatment of chronic uremic anemia in patients undergoing periodic extracorporeal dialysis with large doses of anabolic androgens].
Pentangelo C; Mazza L; Scoppa F
Rass Int Clin Ter; 1971 Oct; 51(20):1268-76. PubMed ID: 5137470
[No Abstract] [Full Text] [Related]
56. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
Mora C; Macía ML; García J; Navarro JF
Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
[No Abstract] [Full Text] [Related]
57. Effects of androgen therapy on prostatic markers in hemodialyzed patients.
Teruel JL; Aguilera A; Avila C; Ortuño J
Scand J Urol Nephrol; 1996 Apr; 30(2):129-31. PubMed ID: 8738058
[TBL] [Abstract][Full Text] [Related]
58. In-depth review effect of androgens on anemia and malnutrition in renal failure: implications for patients on peritoneal dialysis.
Navarro JF; Mora C
Perit Dial Int; 2001; 21(1):14-24. PubMed ID: 11280492
[TBL] [Abstract][Full Text] [Related]
59. Anabolic steroids in the treatment of malnourished CAPD patients: a retrospective study.
Dombros NV; Digenis GE; Soliman G; Oreopoulos DG
Perit Dial Int; 1994; 14(4):344-7. PubMed ID: 7827183
[TBL] [Abstract][Full Text] [Related]
60. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients.
Buchwald D; Argyres S; Easterling RE; Oelshlegel FJ; Brewer GJ; Schoomaker EB; Abbrecht PH; Williams GW; Weller JM
Nephron; 1977; 18(4):232-8. PubMed ID: 323739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
